SKLAR CORP
SC 13D/A, 1998-12-23
MEDICAL, DENTAL & HOSPITAL EQUIPMENT & SUPPLIES
Previous: SKLAR CORP, SC 13D, 1998-12-23
Next: MERRILL LYNCH & CO INC, 424B5, 1998-12-23



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934
                               (Amendment No. 1) *

                                SKLAR CORPORATION
                                (Name of Issuer)

      COMMON STOCK, $0.10 par value, Series A Convertible Preferred Stock,
                                 $0.10 par value
                         (Title of Class of Securities)

                                    58405330
                                 (CUSIP Number)

  Bari Krein, Esquire 2500 One Liberty Place, Philadelphia, Pennsylvania 19103
       (Name, Address and Telephone Number of Person Authorized to Receive
                          Notices and Communications)

                                November 30, 1998
             (Date of Event which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-l(b)(3) or (4), check the following box |_|.

Check the following box if a fee is being paid with the statement |_|. (A fee is
not required only if the reporting person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

Note: Six copies of this statement, including all exhibits, should be filed with
the Commission. See Rule 13d-l(a) for other parties to whom copies are to be
sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).

<PAGE>
                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO.  58403300                                       Page  1 of 4 Pages
- --------------------------------------------------------------------------------

- --------------------------------------------------------------------------------
1         NAME OF REPORTING PERSON      Donald Taylor
          S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
- --------------------------------------------------------------------------------
2         CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*          (a) |_|
                                                                     (b) |_|
- --------------------------------------------------------------------------------
3         SEC USE ONLY
- --------------------------------------------------------------------------------
4         SOURCE OF FUNDS*
                                       OO
- --------------------------------------------------------------------------------
5         CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
          ITEMS 2(D) OR 2(E) |_|
- --------------------------------------------------------------------------------
6         CITIZENSHIP OR PLACE OF ORIGINATION
                            United States of America
- --------------------------------------------------------------------------------


- --------------------------------------------------------------------------------
      NUMBER OF        7   SOLE VOTING POWER
       SHARES                 297,915 shares of Common Stock   (See Item 5(a))
     BENEFICIALLY      ---------------------------------------------------------
      OWNED BY         8   SHARED VOTING POWER
       EACH                 None.
      REPORTING        ---------------------------------------------------------
       PERSON          9   SOLE DISPOSITIVE POWER
       WITH                  297,915 shares of Common Stock  (See Item 5(a))
                       ---------------------------------------------------------
                       10  SHARED DISPOSITIVE POWER
                             None.
- --------------------------------------------------------------------------------
11      AGGREGATED AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
        297,915 shares of Common Stock
        (See Item 5(a))
- --------------------------------------------------------------------------------
12      CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*
                                                                            |_|
- --------------------------------------------------------------------------------
13      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 27.2% of Common
        Stock (See Item 5(a))
- --------------------------------------------------------------------------------
14      TYPE OF REPORTING PERSON*
                                       IN
- --------------------------------------------------------------------------------
<PAGE>
                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO.  58403300                                       Page  2 of 4 Pages
- --------------------------------------------------------------------------------

               Item 1.     Security and Issuer.

                  This Schedule 13D report relates to the Common Stock, par
               value $.10 per share of Sklar Corporation (the "Issuer"). The
               principal executive offices of the Issuer are located at 889
               South Matlack Street, West Chester, Pennsylvania, 19382.

               Item 2.     Identity and Background.

                  (a)  This statement is filed by Donald Taylor.

                  (b) His address is 241 Clonmell-Upland Road, West Grove, PA
                      19390.

                  (c) Donald Taylor ("Taylor") was appointed a Director of the
               Issuer in November, 1988 and was elected President in January
               1989. From 1986 to 1989 he was retained by the Issuer as a
               consultant. The Issuer is engaged in the business of importing
               and distributing surgical, dental and veterinary hand held
               precision stainless steel instruments. The principle business
               address of the Issuer is as set forth in Item 1.

                  (d) Taylor has not been convicted in a criminal proceeding
               (excluding traffic violations or similar misdemeanors) during the
               last five years.

                  (e) Taylor has not been a party, during the last five years,
               to any civil proceeding or a judicial administrative body of
               competent jurisdiction which resulted his being subjected to a
               judgment, decree or final order enjoining future violations of,
               or prohibiting or mandating activities subject to, federal or
               state securities laws or finding any violation with respect to
               such laws.

                  (f) Taylor is a citizen of the United States of America.

               Item 3.     Source and Amount of Funds or Other Consideration.

                  The funds for all acquisitions by Donald Taylor described
               herein were personal funds. The amount of funds concerned in the
               acquisition of such securities as of the date of this report,
               aggregates approximately $25,000.

<PAGE>

                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO.  58403300                                          Page  3 of 4 Pages
- --------------------------------------------------------------------------------

               Item 4.     Purpose of Transaction.

                           The Board of Directors of the Issuer is planning to
               propose a 1-for-50,000 reverse stock split of the Company's
               Common Stock to the Issuer's Shareholders. In lieu of issuing any
               fractional shares, the Company will make a cash payment to
               Shareholders holding less than 50,000 shares of Common Stock. If
               effectuated, the transaction would enable the Company to
               deregister it Common Stock under Section 12(g) of the Securities
               and Exchange Act of 1934.
                  Following the proposed reverse stock split, the Company
               believes that there will be approximately 11 outstanding shares
               of Common Stock of the Issuer.
                  On November 30, 1998, Taylor exercised his option to purchase
               100,000 shares of Common Stock which the Company granted him in
               May, 1993 as consideration for services to the Company. (See Item
               5(c)). His decision to exercise his options at that point may
               have been influenced by the possibility of the reverse stock
               split. Taylor intends to hold these additional shares for
               investment purposes.
                  Except as described in this Schedule 13D, including this Item
               4, neither Taylor nor the Issuer have any plans or proposals
               which relate to or would result in; the acquisition by any person
               of additional securities of the Issuer, or the disposition of
               securities of the Issuer; an extraordinary corporate transaction,
               such as a merger, reorganization or liquidation, involving the
               Issuer or any of its subsidiaries; a sale or transfer of a
               material amount to assets of the Issuer or any of its
               subsidiaries; any change in the present board of directors or
               management of the Issuer, including any plans or proposals to
               change the number or term of directors or to fill any existing
               vacancies on the Board; any material change in the Issuer's
               business or corporate structure; causing the Issuer's securities
               to cease to be authorized to be quoted in an inter-dealer
               quotation system; or any action similar to any of those
               enumerated above.

               Item 5.     Interest in Securities of the Issuer.

                  (a) Taylor is presently the beneficial owner of 297,915 shares
               of Common Stock of the Issuer; which represents approximately
               27.2% of the Issuer's 1,093,423 shares of outstanding Common
               Stock.
                  If the proposed reverse stock split is effected, it is likely
               that Taylor will be the beneficial owner of 5 shares of Common
               Stock; which will represent approximately 45.5% of the Issuer's
               11 outstanding shares of Common Stock.

<PAGE>
                                  SCHEDULE 13D
- --------------------------------------------------------------------------------
CUSIP NO.  58403300                                       Page  4 of 4 Pages
- --------------------------------------------------------------------------------

                  (b) Taylor has the sole power to vote or to direct the vote of
               the 297,915 shares of Common Stock, and will continue to have
               sole power to vote or direct the 5 shares of Common Stock
               following the effectiveness of the reverse stock split if
               proposed as referred to in Item 5(a) above, and has the sole
               power to dispose or direct the disposition of such shares.

                  (c) On November 30, 1998 Taylor exercised his right to
               purchase 100,000 shares of Common Stock, at $0.25 per share. The
               Company granted him this option in May, 1993, as consideration
               for services to the Company.

                  (d) No person other than Taylor has the right to receive or
               the power to direct the receipt of dividends from, or the
               proceeds from the sale of the securities referred to in this
               Schedule 13D as being owned by him.

               Item 6.     Contract, Arrangements, Understanding or Relations 
                           with Respect to the Securities of the Issuer

               None.

               Item 7.     Materials to be Filed as Exhibits

               None.

<PAGE>

                                    SIGNATURE

                  After reasonable inquiry and to the best of my knowledge and
               belief, the undersigned certifies that the information set forth
               in the Statement is true, correct and complete.

               DATED:      December 21, 1998.


                                                    /s/ Donald Taylor
                                                    ------------------


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission